Study of Crenolanib in Combination With Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Activating FLT3 Mutations
Clinical trial NCT02298166 · TERMINATED
Trial details
- NCT number
- NCT02298166
- Sponsor
- University of Ulm
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-17
- Primary completion
- 2020-03-09
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.